GPC3 and hepatocellular carcinoma: A Naïve Bayes classifier was employed to predict IHC marker expression in HCC, using selected clinical biomarkers and radiomic features.<h4>Results</h4>For GPC3, the radiomics classifier achieved a macro-average area under the receiver operating characteristic curve (AUC) of 0.700, indicating strong performance.